To Fight Drug Resistant Infections ™
About
Our mission is to decrease the quantity and severity of infections that cause human suffering and death through the creation and development of novel, targeted, antimicrobial therapies:
The Company’s lead technology, Veriox®, is a first-of-its-kind, proprietary peracid/hydrogen peroxide based non-systemic, non-resistant antimicrobial agent. Veriox® features a novel Mechanism of Action (M of A) that reduces the likelihood of contributing to resistance against Gram+, Gram-, viral, fungal and chemical/biological warfare pathogens.
The Veriox® platform has numerous anti-infective applications including: Surface Disinfectants (i.e. hospital patient rooms, operating rooms, ventilators, etc.), Coatings for Surgical Devices, and other applications where a topical antimicrobial agent is desired.

active agent with low
systemic exposure

therapeutic efficacy

hospitals, insurers,
and patients

on resistant and preventable
infection
PipeLine
Armis is focused on efficacious, non-systemic, non-resistant antimicrobials that work as monotherapies and/or may increase the efficacy of existing systemic antibiotics.